Opioid Use Disorder (OUD) Market to Witness Boost in Growth Owing to the Ongoing Clinical Developmental Activities and Initiative by Major Pharma Giants

As per DelveInsight, the Opioid Use Disorder Market is anticipated to grow in the coming years owing to the increasing incidence of opioid addiction, rise in the number of opioids prescriptions in leading countries like US, Europe, increasing schemes by governments aimed at curbing over-prescription opioid consumption, growing awareness, and the launch of the novel emerging therapies.

DelveInsight's "Opioid Use Disorder (OUD) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Opioid Use Disorder Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Opioid Use Disorder market report covers emerging drugs, treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Opioid Use Disorder (OUD): An Overview
OUD is a chronic disorder that usually requires both medications for opioid use disorder and psychosocial treatment and support. Current treatments are based on medication-assisted treatment (MAT) with an opioid agonist or an opioid antagonist. The most commonly abused opioids are codeine, oxycodone, hydrocodone, morphine, and fentanyl. Physical dependence is the most harmful long-term effect, and withdrawal symptoms occur if opioid use is abruptly reduced.

Opioid use disorders affect over 16 million people worldwide, over 2.1 million in the United States, and there are over 120,000 deaths worldwide annually attributed to opioids. Two types of patients suffer from OUD: patients who are addicted to non-medical opioids and patients addicted to medical opioids. The prevalence of opioid use and dependency varies by age and gender. Men are more likely to use opioids, become dependent on various opioids, and they account for the majority of opioid-related overdoses.

Opioid Use Disorder (OUD) Market Key Facts
• According to the American Psychiatric Association, in 2017, around 72,000 people in the US died of an overdose of drugs, which included illicit drugs and prescription opioids.
• Deaths due to opioid use tend to skew at older ages, with overdoses from opioids highest among individuals between the ages of 40 and 50.
• According to the CDC, the age-adjusted drug poisoning death rate involving opioid analgesics increased to 7.0 per 100000, mounting to the deaths of over 15,000 people due to overdose in 2017.
• The NIH reports that in 2015 nearly 92 million Americans used prescription opioids. This heightening dependency on opioids in the US and worldwide is likely to fuel the opioid use disorder market trends in the near future.

Opioid Use Disorder (OUD) Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Opioid Use Disorder market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Opioid Use Disorder market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How the Opioid Use Disorder Market will Grow by 2032:
https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Opioid Use Disorder (OUD) Epidemiology
The epidemiology section covers detailed insights into the historical and current Opioid Use Disorder patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Opioid Use Disorder Epidemiology, Segmented by -
• Prevalent Cases of Opioid Use Disorder
• Age-Specific Cases of Opioid Use Disorder
• Diagnosed and Treated Cases of Opioid Use Disorder
• Gender-Specific Cases of Opioid Use Disorder

Opioid Use Disorder (OUD) Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Opioid Use Disorder market or expected to get launched in the market during the study period. The analysis covers the Opioid Use Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Opioid Use Disorder Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Opioid Use Disorder (OUD) Therapeutics Assessment
The pipeline for Opioid Use Disorder is not robust. Despite that, the current scenario anticipates a positive shift in the market in the coming years.

Some of the Key Companies in the Opioid Use Disorder (OUD) Therapeutics Market Include:
• Aphios
• Opiant Pharmaceuticals
• Gamida-Cell
• Kyowa kirin
• Trevena
And many others

Opioid Use Disorder (OUD) Therapies Covered in the Report Include:
• TRV734
• Nalmefene (OPNT003)
• APH-1501
And many more

Learn More About the Emerging Therapies & Key Companies in the Opioid Use Disorder Therapeutics Market:
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Opioid Use Disorder Competitive Intelligence Analysis
4. Opioid Use Disorder Market Overview at a Glance
5. Opioid Use Disorder Disease Background and Overview
6. Opioid Use Disorder Patient Journey
7. Opioid Use Disorder Epidemiology and Patient Population
8. Opioid Use Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Opioid Use Disorder Unmet Needs
10. Key Endpoints of Opioid Use Disorder Treatment
11. Opioid Use Disorder Marketed Products
12. Opioid Use Disorder Emerging Therapies
13. Opioid Use Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Opioid Use Disorder Market Outlook (7 major markets)
16. Opioid Use Disorder Access and Reimbursement Overview
17. KOL Views on the Opioid Use Disorder Market.
18. Opioid Use Disorder Market Drivers
19. Opioid Use Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

DelveInsight is a Business Consulting and Market research, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.